AbbVie (NYSE: ABBV) and Gedeon Richter Plc. ('Richter') today announced a new discovery, co-development and license agreement to advance novel targets for the potential treatment of neuropsychiatric ...
Alto Neuroscience, Inc. ("Alto") , a clinical stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today announced that the Phase 2b ...
Land artist Jon Foreman explains the benefits of working in the great outdoors and using materials he finds in nature. "Once you're really absorbed in it, you're not thinking about any of the ...
This journal utilises an Online Peer Review Service (OPRS) for submissions. By clicking "Continue" you will be taken to our partner site https://mc.manuscriptcentral ...